Nanovision Biosciences
PrivateCompany Overview
Nanovision Biosciences is a biotechnology company developing a nanotechnology-based retinal prosthesis designed to restore sight to patients with degenerative retinal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Sensors, Defense Tech
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanovision Biosciences Comparables
Compare Nanovision Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Science Corporation | 86% | |
| iBionics Inc. | 85% | |
| Bionic Vision Technologies | 83% | |
Nanovision Biosciences Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2024
Grew 114% QoQ, from 97 to 208 employees.
- Jun 19, 2024
Grew 18% QoQ, from 82 to 97 employees.
Nanovision Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanovision Biosciences's valuation, stock price, and market status.